The La Jolla, California, biotech formerly known as Anaphore is looking a little different these days. Under the leadership of former Fate Therapeutics CEO Paul Grayson, Anaphore changed its name ...
Read more
Urologists fell in line with other doctor groups on Friday in recommending careful consideration and discussion when it comes to screening for prostate cancer, rather than a gung-ho approach. At ...
Read more
DURHAM -- Tranzyme Pharma, a Durham-based biopharmaceutical company that discontinued clinical trials for two drug candidates last year, is planning to merge with private drug developer Ocera Therapeutics Inc. in ...
Read more
(Reuters) - Acadia Pharmaceuticals Inc said data from an initial late-stage trial would be sufficient to file for approval for its experimental antipsychotic drug for Parkinson's disease patients, and that ...
Read more
Since Craig C. Mello and Andrew Fire published a paper in Nature on the gene-silencing effect of RNA interference in 1998 (for which they won a Nobel Prize in 2006), ...
Read more
(Reuters) - Isis Pharmaceuticals Inc said it will form an alliance with Swiss drugmaker Roche Holding AG to develop treatments for Huntington's disease, a genetic brain disorder, based on the ...
Read more
A healthcare startup led by a co-founder and former chief operating officer of WebMD works with insurers and employers to provide a social support network for members with chronic conditions. ...
Read more
Cardiac diagnostics firm Critical Care Diagnostics Inc. has landed some new capital as it works with clinical laboratories to make its cardiac biomarker assay, ST2, available to physicians.The company announced ...
Read more
What better way to make use of having a doctor on your talk show then getting an exam from him? Stephen Colbert took every advantage when he hosted cardiologist Dr. ...
Read more
WASHINGTON (Reuters) - A U.S. appeals court ruled on Friday that the Food and Drug Administration (FDA) acted correctly when it denied fast-track approval of two stem cell-related medical devices ...
Read more
While venture capitalists are usually focused on investing in innovation, this healthcare VC is turning the tables and doing some creative thinking of its own.Last week, life sciences venture firm ...
Read more
If you want some perspective of how electronic personal health records have evolved, Humetrix has some interesting insights on the subject. It started developing them in 1991 as smart cards ...
Read more
While many existing therapies for cancer aim at killing cancer cells that already exist, Kalos Therapeutics is taking a different approach that it thinks could someday be used to complement ...
Read more
Piggybacking off a $21 million round completed last year, Elcelyx Therapeutics has secured a $20 million series C to fund late-stage clinical development of its drug candidates for type 2 ...
Read more
One approach pharmaceutical companies have been taking to replenish their drug development pipelines is not only investing in early stage biotechnology companies, but also opening innovation centers to help these ...
Read more
